Abdulkader Puranwala
Stock Analyst at ICICI Securities
(2.32)
# 2,911
Out of 4,339 analysts
39
Total ratings
60%
Success rate
2.1%
Average return
Main Sectors:
Stocks Rated by Abdulkader Puranwala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹8,840 → ₹8,820 | $8,216.50 | +7.34% | 3 | Feb 12, 2026 | |
| NSE: GLENMARK Glenmark Pharmaceuticals Limited | Maintained: Sell | ₹1,570 → ₹1,640 | $2,347.10 | -30.13% | 3 | Feb 3, 2026 | |
| NSE: GLAND Gland Pharma Limited | Maintained: Buy | ₹2,115 → ₹2,275 | $2,330.00 | -2.36% | 2 | Jan 29, 2026 | |
| NSE: AKUMS Akums Drugs and Pharmaceuticals Limited | Maintained: Buy | ₹655.00 → ₹600.00 | $536.60 | +11.82% | 3 | Dec 22, 2025 | |
| NSE: SUNPHARMA Sun Pharmaceutical Industries Limited | Maintained: Buy | ₹1,800 → ₹1,965 | $1,835.30 | +7.07% | 2 | Nov 6, 2025 | |
| NSE: NATCOPHARM NATCO Pharma Limited | Maintained: Sell | ₹890.00 → ₹810.00 | $1,182.30 | -31.49% | 2 | Aug 14, 2025 | |
| NSE: ALKEM Alkem Laboratories Limited | Upgraded: Buy | ₹5,900 → ₹6,065 | $5,405.50 | +12.20% | 3 | Aug 13, 2025 | |
| NSE: METROPOLIS Metropolis Healthcare Limited | Maintained: Buy | ₹2,400 | $544.00 | +341.18% | 1 | Aug 11, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Upgraded: Hold | ₹855.00 | $959.65 | -10.91% | 1 | Aug 8, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Downgraded: Sell | ₹630.00 | $769.30 | -18.11% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹5,400 | $6,824.00 | -20.87% | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,110 → ₹1,950 | $2,252.90 | -13.44% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹900.00 | $751.35 | +19.78% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,445 → ₹1,300 | $1,451.40 | -10.43% | 2 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹590.00 | $660.10 | -10.62% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,900 → ₹1,500 | $1,605.40 | -6.57% | 2 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,000 | $1,239.50 | -19.32% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹910.00 → ₹486.62 | $516.80 | -5.84% | 2 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,200 | $1,326.80 | -9.56% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,400 | $431.35 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,250 | $2,303.60 | n/a | 1 | Feb 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,000 | $1,087.00 | n/a | 1 | Feb 6, 2025 |
Apollo Hospitals Enterprise Limited
Feb 12, 2026
Maintained: Buy
Price Target: ₹8,840 → ₹8,820
Current: $8,216.50
Upside: +7.34%
Glenmark Pharmaceuticals Limited
Feb 3, 2026
Maintained: Sell
Price Target: ₹1,570 → ₹1,640
Current: $2,347.10
Upside: -30.13%
Gland Pharma Limited
Jan 29, 2026
Maintained: Buy
Price Target: ₹2,115 → ₹2,275
Current: $2,330.00
Upside: -2.36%
Akums Drugs and Pharmaceuticals Limited
Dec 22, 2025
Maintained: Buy
Price Target: ₹655.00 → ₹600.00
Current: $536.60
Upside: +11.82%
Sun Pharmaceutical Industries Limited
Nov 6, 2025
Maintained: Buy
Price Target: ₹1,800 → ₹1,965
Current: $1,835.30
Upside: +7.07%
NATCO Pharma Limited
Aug 14, 2025
Maintained: Sell
Price Target: ₹890.00 → ₹810.00
Current: $1,182.30
Upside: -31.49%
Alkem Laboratories Limited
Aug 13, 2025
Upgraded: Buy
Price Target: ₹5,900 → ₹6,065
Current: $5,405.50
Upside: +12.20%
Metropolis Healthcare Limited
Aug 11, 2025
Maintained: Buy
Price Target: ₹2,400
Current: $544.00
Upside: +341.18%
Fortis Healthcare Limited
Aug 8, 2025
Upgraded: Hold
Price Target: ₹855.00
Current: $959.65
Upside: -10.91%
Krishna Institute of Medical Sciences Limited
Aug 8, 2025
Downgraded: Sell
Price Target: ₹630.00
Current: $769.30
Upside: -18.11%
Aug 7, 2025
Maintained: Sell
Price Target: ₹5,400
Current: $6,824.00
Upside: -20.87%
Aug 7, 2025
Maintained: Hold
Price Target: ₹2,110 → ₹1,950
Current: $2,252.90
Upside: -13.44%
Aug 6, 2025
Maintained: Hold
Price Target: ₹900.00
Current: $751.35
Upside: +19.78%
Aug 6, 2025
Upgraded: Buy
Price Target: ₹1,445 → ₹1,300
Current: $1,451.40
Upside: -10.43%
Aug 5, 2025
Maintained: Hold
Price Target: ₹590.00
Current: $660.10
Upside: -10.62%
Aug 1, 2025
Maintained: Hold
Price Target: ₹2,900 → ₹1,500
Current: $1,605.40
Upside: -6.57%
Jul 29, 2025
Maintained: Sell
Price Target: ₹1,000
Current: $1,239.50
Upside: -19.32%
Jul 25, 2025
Maintained: Buy
Price Target: ₹910.00 → ₹486.62
Current: $516.80
Upside: -5.84%
Jul 24, 2025
Maintained: Hold
Price Target: ₹1,200
Current: $1,326.80
Upside: -9.56%
Mar 25, 2025
Initiated Coverage: Buy
Price Target: ₹1,400
Current: $431.35
Upside: n/a
Feb 17, 2025
Upgraded: Buy
Price Target: ₹2,250
Current: $2,303.60
Upside: n/a
Feb 6, 2025
Maintained: Hold
Price Target: ₹1,000
Current: $1,087.00
Upside: n/a